) .
INTRODUCTION
investigated fall into two main approaches: elimination or modification of the CNVM (by laser, Treatment of benign disease by ionizing radiations chemotherapeutic agents, photodynamic therapy, has always aroused keen interest. One such transpupillary thermotherapy, feeder vessel important condition is age-related macular photocoagulation or novel techniques such as degeneration (ARMD). This disease is the leading submacular surgery and macular translocation) or cause of blindness in the west and it's prevalence prevention of the formation of CNVM (by laser varies from 1% in patients aged 65 to 74 years, to prophylaxis, diet or gene targeting. [3] Whilst almost 10% in patients aged 85 onwards.
[1,2] It is however a no therapy restores normal visual acuity (VA), any lesser known cause of blindness in the Indian significant visual improvement or even maintenance
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subcontinent, behind commoner conditions such as cataract. There are three major forms of macular degeneration. i) Dry form ii) wet form iii) Pigment epithelial detachment (PED). The dry form, which accounts for 85-90% of patients with ARMD, involves thinning of the macula. Usually no effective treatment is available for this disease. In the wet form (10%) abnormal vessels grow under the retina and lift the retina up. [2] This is known as subretinal neovascularisation (SRNV). ARMD may lead to loss of vision by atrophy of the retinal pigment epithelium or by the development of choroidal neovascular membranes (CNVM) under the macula, which leak serous fluid and blood and ultimately cause a blinding disciform scar. Options currently being of the VA over the natural history may be regarded as beneficial. Radiation therapy has been used in treatment of this disorder with varying results ever since the first trial reported by Chakravorty et al. Radiotherapy affects the evolution of exudative macular degeneration directly by endothelial toxicity, leading to capillary closure and/or indirectly through its attenuating effects on the inflammatory response, mediated by macrophages and other inflammatory cells. [4, 5] We conducted this study to see the response and the toxicity of radiotherapy in the treatment of this disease and to evaluate the role of other factors determining response to radiotherapy. We also intended to see if there was any dose response effect of radiation. 
MATERIALS AND METHODS
63 patients were enrolled in this retrospective study. The inclusion criteria for this study were 1) Patients were not considered suitable for LASER photocoagulation by the referring ophthalmologist due to subfoveal location 2) Eyes having sub retinal neovascular membrane 3) Increase in size in neovascular membrane during the past six months or onset of symptoms lesser than six months 4) Age greater than 30 years 5) Patients willing for radiotherapy. In all cases, the initial work up included a detailed history and the total duration of symptoms, history of smoking, diabetes mellitus and hypertension. Pretreatment ophthalmologic evaluation included detailed examination of the fundi, VA and Fundus fluorescein angiography (FFA) in all the cases. All the patients were explained the investigative nature of the study and in our hospital, 16 did not receive radiotherapy. Reasons for this were varied and included patients lost after first outpatient months. At each follow-up, both the ophthalmologist and the visit, patients who were not given radiotherapy because their radiation oncologist evaluated the patient. The response was vision remained stable over past six months or more and graded subjectively as 1) no change 2) worse 3) better. VA and patients who were unwilling for radiotherapy and opted for funduscopy was taken by the qualified ophthalmologist was other forms of treatment. One patient was 24 years of age and repeated at each follow-up for objective improvement and to was not treated in view of the rare occurrence of ARMD in this assess the healing of SRNV. age group. In the final analysis only 47 remaining patients were considered. Since 11 patients had bilateral involvement Statistical so in all 58 eyes were treated.
The analysis was done using SPSS software (version 10). The deterioration free survival was calculated using Kaplan Meyer Radiation treatment survival analysis. Long rank test was used to compare the groups In each patient, immobilization was achieved by use of in the survival analysis. The Chi square test was used to see the thermoplastic mask. CT planning was done for all patients in significance of other factors affecting the response to radiation. the supine position and fiducial radio-opaque markers placed at the lateral canthi. All the relevant structures such as the RESULTS lens, posterior retina and the contra lateral eye were outlined. It was ensured that the 90% isodose adequately covered the Patient characteristics are given in Table 1 . The median follow ipsilateral macula and optic disc, with less that 50% falling on up was 7.23 months (SD 9.67). the ipsilateral posterior lens capsule. Patients were treated most commonly with a single lateral portal with 5-15 degree
The mean improvement in the VA in the entire group was of posterior tilt [ Figure 1 ]. Asymmetric fields of 3×3 cm size were 0.44 line. (Median 1, SD 1.04). Overall 75% of the eyes showed used in all the patients to prevent divergence into the opposite either steady vision or an improvement in subjective vision. eye. The other portals, which were used were true lateral portals (in patients where the opposite eye or lens was not a consideration) or bilateral fields (in patients in which both eyes were simultaneously treated). One of the following radiotherapy fractionation schedules was employed in all the patients in this dose escalation study. a) 15 Gy/5#/1 week (five patients) b) 20 Gy/5#/1 week (19 patients) c) 22.5Gy/5#/1 week (21 patients) d) 25 Gy/5#/1 week (2 patients). The dose was prescribed at Dmax in the patients treated with ipsilateral technique. In patients who were treated with bilateral parallel opposing portals the dose was prescribed at the mid separation. All the patients completed the planned radiotherapy as scheduled.
Patients were seen at follow-up monthly for three months, three monthly for the first year and subsequently every six Improved or steady VA was recorded in 77% of the eyes [ Table  2 ]. In the present study, there was no gain in line once the symptom duration had crossed 10 months. Figure 2 presents the relation between initial duration of symptoms and gain/ loss of lines in VA.
The deterioration free survival was significantly different in the group that had a relatively short duration of symptoms (<4 months) compared to the group having longer duration of symptoms (>4 months). (Log rank P=0.01) [ Figure 3 ]. radiotherapy delivered. However the duration of initial symptoms and the presence or absence of initial scarring was highly significant. (P=0.003) [ Table 3 ].
DISCUSSION
We found that duration of initial symptoms had a profound effect on shown to be important and significant as a prognostic variable for visual stability of improvement. This is explained by the fact that the neovasculature structure will be more susceptible to radiotherapy in early stages rather that when the active proliferation has settled and had been replaced by fibrosis or scarring. This finding strengthens the belief that radiotherapy in ARMD should be started as soon as possible. On the same lines, even initial scarring which is an indicator of the duration of the ARMD onset is a significant variable. Fibrotic and scarred retinas have much less proloferative tissues and hence poor response to radiotherapy.
Although there is a definite dose response curve with increasing dose of radiotherapy, the difference between response to low have shown a dose response effect in ARMD with a demonstrable benefit with using radiotherapy. The only randomized controlled trial that did not show a clear benefit that although radiation inhibits CRNV, its effectiveness in improving VA might not be evident. [6] log rank p=0.21
Various groups have reported their results on the course and response of ARMD patients to radiotherapy. The results have been variable and in most of the series the numbers are small and the follow up short. Also different doses and fractionation schedules have been employed and therefore it is hardly surprising that the results have been varied. Subjective means, VA and FFA have usually assessed response. Table 4 presents important studies in ARMD using radiotherapy as the treatment modality. Most of the nonrandomized and randomized studies was by Marcus.
[9] However, they used low BED (14Gy/7#). We have used a dose higher that this in nearly half of our patients. or high dose does not attain significance. However factors such
Although this group has shown higher VA improvement in our as age and sex were not found to have any bearing on study, this difference is not significant in our analysis. It may be radiotherapy response. Smoking, diabetes and hypertension important to stratify the cases before for initial duration of too were not observed as risk factors, though the absolute symptoms and perhaps even initial VA before they are numbers are small. Initial visual acuty has also been suggested randomized for different radiotherapy dose regimes. to be an important prognostic determinant of the benefit from radiotherapy. Our study has not demonstrated this to be a Studies analyzing the effect of giving a higher dose of significant independent variable.
radiotherapy as compared to a lower dose too have demonstrated benefit with the former.
[10, 14] In our study, as many as 74% of the analysed subjects had either comparing two groups of patients who were treated with a stable or improved vision at last follow up and this compares high or a low dose of radiotherapy (10 and 20 gray), there was very favorably with historical controls.
[1, 6, 7] Similarly 77% patients no difference in the response rates, However, the number of have shown objective response to radiotherapy (in visual acuity).
subjects was quite small. [15] Other groups such as Gelisken et al have indicated that radiotherapy can be effective in regressing Some authors have found a discrepancy between improvement the leakage of the CNV in ARMD. However, despite treatment in CRNV and improvement in visual acuity. One study concluded visual deterioration could continue and new CNV lesions still develop. [16] Altered fractionation too needs to be explored to finally arrive at the final optimal fractionation in treating ARMD. While hypo fractionation may be beneficial since the targeted tissues (arterioles) are essentially radioresistant and by providing a short treatment time, hyperfractionation may benefit by sparing late effects especially retinal sequelae besides being beneficial for the acutely proliferating neovasculature. In a solitary study of its kind, Marcus found a benefit of using (3GyX 5 fractions) compared to (2GyX 7 fractions). [14] Possible toxic effects on critical structures such as lens and retina are always of concern while irradiating the eye. Cataract as a
